Patrick Sanz

810 total citations
19 papers, 627 citations indexed

About

Patrick Sanz is a scholar working on Molecular Biology, Genetics and Virology. According to data from OpenAlex, Patrick Sanz has authored 19 papers receiving a total of 627 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 10 papers in Genetics and 6 papers in Virology. Recurrent topics in Patrick Sanz's work include Bacillus and Francisella bacterial research (14 papers), Bacterial Genetics and Biotechnology (9 papers) and Poxvirus research and outbreaks (6 papers). Patrick Sanz is often cited by papers focused on Bacillus and Francisella bacterial research (14 papers), Bacterial Genetics and Biotechnology (9 papers) and Poxvirus research and outbreaks (6 papers). Patrick Sanz collaborates with scholars based in United States, Spain and France. Patrick Sanz's co-authors include Alison D. O’Brien, Bernard Moss, Robert J. Cybulski, Farhang Alem, Stephen C. Darnell, Panayampalli S. Satheshkumar, Robert L. Bull, Luis C. Antón, Susan B. Rasmussen and Humberto M. Carvalho and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Virology and Infection and Immunity.

In The Last Decade

Patrick Sanz

19 papers receiving 621 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Patrick Sanz United States 13 438 222 149 131 122 19 627
Marthandan Mahalingam United States 16 433 1.0× 138 0.6× 422 2.8× 181 1.4× 188 1.5× 24 789
Wayne Conlan Canada 17 703 1.6× 438 2.0× 171 1.1× 218 1.7× 154 1.3× 20 921
Nrusingh P. Mohapatra United States 14 634 1.4× 428 1.9× 233 1.6× 168 1.3× 62 0.5× 19 763
Maria Cândida M. Mellado Portugal 9 310 0.7× 114 0.5× 122 0.8× 297 2.3× 43 0.4× 10 783
S F Little United States 9 798 1.8× 391 1.8× 215 1.4× 274 2.1× 141 1.2× 10 869
Jitka Štokrová Czechia 18 512 1.2× 243 1.1× 200 1.3× 104 0.8× 69 0.6× 54 977
Julie A. Lovchik United States 19 585 1.3× 247 1.1× 169 1.1× 407 3.1× 54 0.4× 31 1.1k
Nicola J. Walker United Kingdom 13 286 0.7× 161 0.7× 55 0.4× 121 0.9× 26 0.2× 19 495
Deborah M. B. Post United States 16 344 0.8× 143 0.6× 142 1.0× 70 0.5× 33 0.3× 22 776
Elizabeth V. L. Grgacic Australia 12 254 0.6× 84 0.4× 96 0.6× 286 2.2× 143 1.2× 20 795

Countries citing papers authored by Patrick Sanz

Since Specialization
Citations

This map shows the geographic impact of Patrick Sanz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick Sanz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick Sanz more than expected).

Fields of papers citing papers by Patrick Sanz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patrick Sanz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick Sanz. The network helps show where Patrick Sanz may publish in the future.

Co-authorship network of co-authors of Patrick Sanz

This figure shows the co-authorship network connecting the top 25 collaborators of Patrick Sanz. A scholar is included among the top collaborators of Patrick Sanz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patrick Sanz. Patrick Sanz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Goll, Johannes B., Steven E. Bosinger, Hasse Walum, et al.. (2023). The Vacc-SeqQC project: Benchmarking RNA-Seq for clinical vaccine studies. Frontiers in Immunology. 13. 1093242–1093242. 2 indexed citations
2.
Chang, Yie‐Hwa, Duc M. Duong, Johannes B. Goll, et al.. (2020). Proteomic Analysis of Human Immune Responses to Live-Attenuated Tularemia Vaccine. Vaccines. 8(3). 413–413. 6 indexed citations
3.
Maner-Smith, Kristal, Johannes B. Goll, Jennifer K. Colucci, et al.. (2020). Alterations in the Human Plasma Lipidome in Response to Tularemia Vaccination. Vaccines. 8(3). 414–414. 9 indexed citations
4.
Goll, Johannes B., Shuzhao Li, James L. Edwards, et al.. (2020). Transcriptomic and Metabolic Responses to a Live-Attenuated Francisella tularensis Vaccine. Vaccines. 8(3). 412–412. 14 indexed citations
5.
Natrajan, Muktha S., Nadine Rouphael, Lilin Lai, et al.. (2019). Systems Vaccinology for a Live Attenuated Tularemia Vaccine Reveals Unique Transcriptional Signatures That Predict Humoral and Cellular Immune Responses. Vaccines. 8(1). 4–4. 24 indexed citations
6.
Guina, Tína, Lynda Lanning, Kristian Shawn Omland, et al.. (2018). The Cynomolgus Macaque Natural History Model of Pneumonic Tularemia for Predicting Clinical Efficacy Under the Animal Rule. Frontiers in Cellular and Infection Microbiology. 8. 99–99. 12 indexed citations
7.
Cote, Christopher K., Joel A. Bozue, Patrick Sanz, et al.. (2012). Characterization of a multi-component anthrax vaccine designed to target the initial stages of infection as well as toxaemia. Journal of Medical Microbiology. 61(10). 1380–1392. 28 indexed citations
8.
Cybulski, Robert J., Patrick Sanz, & Alison D. O’Brien. (2009). Anthrax vaccination strategies. Molecular Aspects of Medicine. 30(6). 490–502. 51 indexed citations
9.
Satheshkumar, Panayampalli S., Luis C. Antón, Patrick Sanz, & Bernard Moss. (2009). Inhibition of the Ubiquitin-Proteasome System Prevents Vaccinia Virus DNA Replication and Expression of Intermediate and Late Genes. Journal of Virology. 83(6). 2469–2479. 90 indexed citations
10.
Crawford, Matthew A., Marie D. Burdick, Patrick Sanz, et al.. (2009). Antimicrobial Effects of Interferon-Inducible CXC Chemokines againstBacillus anthracisSpores and Bacilli. Infection and Immunity. 77(4). 1664–1678. 40 indexed citations
11.
Cybulski, Robert J., et al.. (2008). Recombinant Bacillus anthracis spore proteins enhance protection of mice primed with suboptimal amounts of protective antigen. Vaccine. 26(38). 4927–4939. 33 indexed citations
12.
Sanz, Patrick, Louise D. Teel, Farhang Alem, et al.. (2008). Detection of Bacillus anthracis Spore Germination In Vivo by Bioluminescence Imaging. Infection and Immunity. 76(3). 1036–1047. 53 indexed citations
13.
Cybulski, Robert J., Patrick Sanz, Farhang Alem, et al.. (2008). Four Superoxide Dismutases Contribute to Bacillus anthracis Virulence and Provide Spores with Redundant Protection from Oxidative Stress. Infection and Immunity. 77(1). 274–285. 79 indexed citations
14.
Darnell, Stephen C., Humberto M. Carvalho, Patrick Sanz, et al.. (2007). Recombinant Exosporium Protein BclA of Bacillus anthracis Is Effective as a Booster for Mice Primed with Suboptimal Amounts of Protective Antigen. Infection and Immunity. 75(11). 5240–5247. 42 indexed citations
15.
Janes, Brian K., et al.. (2007). Bacillus anthracis Exosporium Protein BclA Affects Spore Germination, Interaction with Extracellular Matrix Proteins, and Hydrophobicity. Infection and Immunity. 75(11). 5233–5239. 77 indexed citations
16.
Sanz, Patrick & Bernard Moss. (1999). Identification of a transcription factor, encoded by two vaccinia virus early genes, that regulates the intermediate stage of viral gene expression. Proceedings of the National Academy of Sciences. 96(6). 2692–2697. 36 indexed citations
17.
Sanz, Patrick & Bernard Moss. (1998). A New Vaccinia Virus Intermediate Transcription Factor. Journal of Virology. 72(8). 6880–6883. 12 indexed citations
18.
Marin, Mona, et al.. (1996). [Child vaccination: the coverage, knowledge and attitudes of the population. A study in a health area].. PubMed. 44(5). 464–8. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026